Literature DB >> 14181031

SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE.

M FOX.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; BLOOD CELL COUNT; CADAVER; CYCLOPHOSPHAMIDE; DRUG THERAPY; EXPERIMENTAL LAB STUDY; KIDNEY TRANSPLANTATION; LIVER; LYMPH NODES; MICE; PATHOLOGY; PHARMACOLOGY; SKIN TRANSPLANTATION; SPLEEN; TISSUE EXTRACTS; TRANSPLANTATION IMMUNOLOGY

Mesh：

Substances：

Year:  1964        PMID： 14181031     DOI： 10.1097/00007890-196407000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.

Authors:  K HELLMANN; D I DUKE; D F TUCKER
Journal:  Br Med J       Date:  1965-09-18

Review 2.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Cyclophosphamide and human organ transplantation.

Authors:  T E Starzl; C G Halgrimson; I Penn; G Martineau; G Schroter; H Amemiya; C W Putnam; C G Groth
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

4.  The immunosuppressive activity of adamantoyl cytarabine. 3. Immunosuppressive specificity in rats.

Authors:  G D Gray; M M Mickelson
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

5.  Suppression of reticuloendothelial function in the rat with cyclophosphamide.

Authors:  R J Sharbaugh; J B Grogan
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

6.  Cyclophosphamide and whole organ transplantation in human beings.

Authors:  T E Starzl; C W Putnam; C G Halgrimson; G T Schroter; G Martineau; B Launois; J L Corman; I Penn; A S Booth; C G Groth; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1971-12

7.  Immunosuppression with cyclophosphamide in the dog.

Authors:  C W Putnam; C G Halgrimson; C G Groth; N Kashiwagi; K A Porter; T E Starzl
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

8.  Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.

Authors:  G A Currie
Journal:  Br Med J       Date:  1970-02-28

9.  Cyclophosphamide therapy in the nephrotic syndrome in childhood.

Authors:  M W Moncrieff; R H White; C S Oggs; J S Cameron
Journal:  Br Med J       Date:  1969-03-15

10.  Effect of cyclophosphamide on Histoplasma capsulatum infections in mice.

Authors:  G C Cozad; T J Lindsey
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.